Science Explorer Back to mapMap
Discussion
Topic · Surgery

Eosinophilic Esophagitis

Eosinophilic Esophagitis is a research topic within Surgery. Science Explorer counts 32k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of eosinophilic esophagitis in both children and adults. It covers various aspects including treatment guidelines, epidemiology, histologic remission, and the use of food elimination diets. The research provides updated consensus recommendations, evidence-based approaches, and insights into the natural history and etiological factors of eosinophilic esophagitis.

  • Eosinophilic Esophagitis
  • Diagnosis
  • Management
  • Children
  • Adults
  • Treatment
  • Guidelines
  • Epidemiology
  • Histologic Remission
  • Food Elimination Diet
Research works
32k
fractional, since 1950
In the world top 10%
3.3k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+9%
the tick is no change
Largest producer
United States
44% of the 10 largest, 2022-now
Eosinophilic Esophagitis

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Eosinophilic Esophagitis research?

By volume, the United States and China publish the most (1.9k and 586 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.9k works
  2. 2 China 586 works
  3. 3 United Kingdom 308 works
  4. 4 Japan 301 works
  5. 5 Italy 290 works
  6. 6 Germany 210 works
  7. 7 Spain 200 works
  8. 8 Canada 175 works
  9. 9 India 171 works
  10. 10 Russia 134 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 43.9%China: 13.9%United Kingdom: 7.3%Japan: 7.1%6 others listed: 27.9%44%largest
United States1,855 · 43.9%China586 · 13.9%United Kingdom308 · 7.3%Japan301 · 7.1%6 others listed1,179 · 27.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Eosinophilic Esophagitis research?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most Eosinophilic Esophagitis research, followed by Mayo Clinic and Harvard University.

By volume, 2022-now

  1. 1 University of North Carolina at Chapel HillUnited States 82 works
  2. 2 Mayo ClinicUnited States 59 works
  3. 3 Harvard UniversityUnited States 50 works
  4. 4 University of CincinnatiUnited States 44 works
  5. 5 Mount Sinai Health SystemUnited States 39 works
  6. 6 Northwestern UniversityUnited States 34 works
  7. 7 AstraZeneca (United Kingdom)United Kingdom 31 works
  8. 8 National Institutes of HealthUnited States 29 works
  9. 9 Sun Yat-sen UniversityChina 28 works
  10. 10 University of TorontoCanada 25 works

Who are the leading researchers in Eosinophilic Esophagitis?

The most-cited researchers publishing on Eosinophilic Esophagitis include George Davey Smith, Walter Churchill Willett and Mark J. Daly.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Walter Churchill Willett United States 411k citations
  3. 3 Mark J. Daly United States 403k citations
  4. 4 Bert Vogelstein United States 373k citations
  5. 5 Hermann Brenner Germany 343k citations
  6. 6 Shizuo Akira Japan 342k citations
  7. 7 Jun Wang China 340k citations
  8. 8 Graeme J. Hankey Australia 316k citations
  9. 9 Gordon Henry Guyatt Canada 315k citations
  10. 10 Gregory Y.H. Lip United Kingdom 311k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Eosinophilic Esophagitis?

The most cited paper in Eosinophilic Esophagitis is "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease" (Yasunori Ogura, Denise K. Bonen, Naohiro Inohara et al., 2001), with 5,051 citations. Next come "IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines" (3,763) and "Global strategy for asthma management and prevention: GINA executive summary" (3,258).

Most cited papers
#PaperReleasedCitations
1 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Yasunori Ogura, Denise K. Bonen, Naohiro Inohara et al. · Nature Open access May 2001 5,051
2 IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines Jochen Schmitz, Alexander M. Owyang, Elizabeth R. Oldham et al. · Immunity Open access Nov 2005 3,763
3 Global strategy for asthma management and prevention: GINA executive summary Eric Donn Bateman, Suzanne S. Hurd, Peter John Barnes et al. · European Respiratory Journal Open access 31 Dec 2007 3,258
4 A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene Richard H. Duerr et al. · Science Open access 26 Oct 2006 3,019
5 Crohn's disease Joana Torres, Saurabh Mehandru, Jean‐Frédéric Colombel et al. · The Lancet 30 Nov 2016 2,720
All 99 most cited papers, with filters and sorting

Where is Eosinophilic Esophagitis research done?

The largest centres of Eosinophilic Esophagitis research in 2022-now are New York (United States), London (United Kingdom), Tokyo (Japan) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cincinnati and Scottsdale.

Largest cities, 2022-now

  1. 1 New YorkUnited States 106 works
  2. 2 LondonUnited Kingdom 104 works
  3. 3 TokyoJapan 87 works
  4. 4 BeijingChina 86 works
  5. 5 Chapel HillUnited States 82 works
  6. 6 PhiladelphiaUnited States 73 works
  7. 7 MadridSpain 59 works
  8. 8 MoscowRussia 56 works
  9. 9 RomeItaly 55 works
  10. 10 ClevelandUnited States 54 works

Where it is the local speciality

  1. CincinnatiUS · 48.5 works11×
  2. ScottsdaleUS · 29.3 works10×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Eosinophilic Esophagitis than the world average.

See Eosinophilic Esophagitis on the map

Where is the best place to study Eosinophilic Esophagitis?

Among universities, judged by research, McMaster University, University of Cincinnati and Humanitas University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 23.68%fractional works in this field (log) →share of work in the world top 10% →McMaster UniversityWashington Universit…Humanitas UniversityUniversity of Cincin…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1McMaster UniversityCanada 72.136.3%5.8×17 +25.1%
2University of CincinnatiUnited States 68.019.8%14.2×44 +1.9%
3Humanitas UniversityItaly 64.825.7%16.2×12 +91.1%
4Washington University in St. LouisUnited States 63.730.3%4.7×18 +10.3%
5University of North Carolina at Chapel HillUnited States 59.913.9%8.8×82 -12.7%
6University of Colorado DenverUnited States 59.320.8%11.9×20 +16.1%
7Nanchang UniversityChina 58.434.2%2.6×10 +216.3%
8Harvard UniversityUnited States 57.914.9%3.0×50 -11.1%
9University of PaduaItaly 57.720.6%4.7×19 +76.2%
10Northwestern UniversityUnited States 56.620.3%7.8×34 -32.3%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Eosinophilic Esophagitis, country by country

Is Eosinophilic Esophagitis research growing?

Output in 2022-2025 was 9% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Eosinophilic Esophagitis.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eosinophilic Esophagitis as a percentage of every work published that year, 0.030% in 2024.

still counting0.020%0.040%0.060%Eosinophilic Esophagitis0.023% in 202519801990200020102020

Fractional works of Eosinophilic Esophagitis over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Eosinophilic Esophagitis10.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Eosinophilic Esophagitis. Posts are plain text and can be reported.